{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-214711","form_type":"8-K","ticker":"PCVX","cik":"0001649094","company_name":"Vaxcyte, Inc.","filed_at":"2024-09-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.954786+00:00","generated_at":"2026-05-31T06:04:55.612096+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Vaxcyte raises $1.42B in underwritten public offering of common stock and pre-funded warrants","bullets":["Sold 10,194,175 shares at $103.00/share and pre-funded warrants to purchase 2,427,184 shares at $102.999/warrant.","Underwriters' 30-day option for additional 1,893,203 shares exercised in full.","Net proceeds expected to be approximately $1.42 billion after discounts and expenses.","Closing expected on or about September 6, 2024, subject to customary conditions.","Offering made under effective shelf registration statement (Form S-3)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-214711","json":"https://secwatch.observer/filing/0001193125-24-214711.json","markdown":"https://secwatch.observer/filing/0001193125-24-214711.md","text":"https://secwatch.observer/filing/0001193125-24-214711.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649094/000119312524214711/0001193125-24-214711-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649094/000119312524214711/d802914d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:04:55.612096+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}